Literature DB >> 20942513

Drug-induced hypoglycaemia: an update.

Chaker Ben Salem1, Neila Fathallah, Houssem Hmouda, Kamel Bouraoui.   

Abstract

Drugs are the most frequent cause of hypoglycaemia in adults. Although hypoglycaemia is a well known adverse effect of antidiabetic agents, it may occasionally develop in the course of treatment with drugs used in everyday clinical practice, including NSAIDs, analgesics, antibacterials, antimalarials, antiarrhythmics, antidepressants and other miscellaneous agents. They induce hypoglycaemia by stimulating insulin release, reducing insulin clearance or interfering with glucose metabolism. Several drugs may also potentiate the hypoglycaemic effect of antidiabetic agents. Administration of these agents to individuals with diabetes mellitus is of most concern. Many of these drugs, and depending on clinical setting, may also induce hyperglycaemia. Drug-induced hepatotoxicity and nephrotoxicity may lead in certain circumstances to hypoglycaemia. Some drugs may also induce hypoglycaemia by causing pancreatitis. Drug-induced hypoglycaemia is usually mild but may be severe. Effective clinical management can be handled through awareness of this drug-induced adverse effect on blood glucose levels. Herein, we review pertinent clinical information on the incidence of drug-induced hypoglycaemia and discuss the underlying pathophysiological mechanisms, and prevention and management.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20942513     DOI: 10.2165/11538290-000000000-00000

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  287 in total

1.  Hypoglycaemia induced by hydroxychloroquine in a non-diabetic patient treated for RA.

Authors:  D U Cansu; C Korkmaz
Journal:  Rheumatology (Oxford)       Date:  2008-01-25       Impact factor: 7.580

2.  Nefazodone-induced hypoglycemia in a diabetic patient with major depression.

Authors:  J K Warnock; F Biggs
Journal:  Am J Psychiatry       Date:  1997-02       Impact factor: 18.112

3.  Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of glimepiride.

Authors:  M Niemi; P J Neuvonen; K T Kivistö
Journal:  Clin Pharmacol Ther       Date:  2001-11       Impact factor: 6.875

4.  Trimethoprim/sulfamethoxazole-induced hypoglycemia in a malnourished patient with severe infection.

Authors:  Z Hekimsoy; S Biberoğlu; A Cömlekçi; O Tarhan; C Mermut; K Biberoğlu
Journal:  Eur J Endocrinol       Date:  1997-03       Impact factor: 6.664

5.  Prolonged toxicity from atenolol overdose in an adolescent.

Authors:  I A Abbasi; S Sorsby
Journal:  Clin Pharm       Date:  1986-10

6.  [Hypoglycemia secondary to intravenous pentamidine treatment without subsequent diabetes mellitus].

Authors:  I Moreno; M A Gonzalo; M Fernández Guerrero; J L Herrera-Pombo
Journal:  Rev Clin Esp       Date:  1993-10       Impact factor: 1.556

7.  Hypoglycemia secondary to tetracycline-induced hepatorenal failure.

Authors:  C B Kahn; H Eichner; S Wagner; J Davis; J J Deller
Journal:  Mil Med       Date:  1975-03       Impact factor: 1.437

8.  Steady-state pharmacokinetics and safety of donepezil HCl in subjects with moderately impaired renal function.

Authors:  Christa F Nagy; Dinesh Kumar; Edward I Cullen; W Kline Bolton; Thomas C Marbury; Maria J Gutierrez; H Wayne Hutman; Raymond D Pratt
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

9.  Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial.

Authors:  Reinhard G Bretzel; Ulrike Nuber; Wolfgang Landgraf; David R Owens; Clare Bradley; Thomas Linn
Journal:  Lancet       Date:  2008-03-29       Impact factor: 79.321

10.  Can insulin-treated diabetics be given beta-adrenergic blocking drugs?

Authors:  A H Barnett; D Leslie; P J Watkins
Journal:  Br Med J       Date:  1980-04-05
View more
  15 in total

Review 1.  Drug-Induced Hyperglycaemia and Diabetes.

Authors:  Neila Fathallah; Raoudha Slim; Sofien Larif; Houssem Hmouda; Chaker Ben Salem
Journal:  Drug Saf       Date:  2015-12       Impact factor: 5.606

Review 2.  Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State.

Authors:  Maya Fayfman; Francisco J Pasquel; Guillermo E Umpierrez
Journal:  Med Clin North Am       Date:  2017-05       Impact factor: 5.456

3.  Glucose-Lowering Agents and the Risk of Hypoglycemia: a Real-world Study.

Authors:  Beini Lyu; Y Joseph Hwang; Elizabeth Selvin; Brian C Jameson; Alex R Chang; Morgan E Grams; Jung-Im Shin
Journal:  J Gen Intern Med       Date:  2022-07-13       Impact factor: 6.473

4.  Norcantharidin toxicity profile: an in vivo murine study.

Authors:  Gabriel Martínez-Razo; María Lilia Domínguez-López; José M de la Rosa; Diego A Fabila-Bustos; Elba Reyes-Maldonado; Eliezer Conde-Vázquez; Armando Vega-López
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-10-03       Impact factor: 3.195

Review 5.  Sulfonylureas and risk of falls and fractures: a systematic review.

Authors:  Kate L Lapane; Shibing Yang; Monique J Brown; Rachel Jawahar; Caleb Pagliasotti; Swapnil Rajpathak
Journal:  Drugs Aging       Date:  2013-07       Impact factor: 3.923

6.  Hypoglycemia in non-diabetic in-patients: clinical or criminal?

Authors:  Krishnarajah Nirantharakumar; Tom Marshall; James Hodson; Parth Narendran; Jon Deeks; Jamie J Coleman; Robin E Ferner
Journal:  PLoS One       Date:  2012-07-02       Impact factor: 3.240

7.  Influence of a strict glucose protocol on serum potassium and glucose concentrations and their association with mortality in intensive care patients.

Authors:  Esther V Uijtendaal; Jeannette E F Zwart-van Rijkom; Dylan W de Lange; Arief Lalmohamed; Wouter W van Solinge; Toine C G Egberts
Journal:  Crit Care       Date:  2015-06-22       Impact factor: 9.097

8.  Toxicological Evaluation of Novel Cyclohexenone Derivative in an Animal Model through Histopathological and Biochemical Techniques.

Authors:  Muhammad Kamil; Arifa Fatima; Sami Ullah; Gowhar Ali; Rasool Khan; Naila Ismail; Mughal Qayum; Marius Irimie; Catalina Georgeta Dinu; Hanadi Talal Ahmedah; Maria Elena Cocuz
Journal:  Toxics       Date:  2021-05-25

Review 9.  Interpreting adverse signals in diabetes drug development programs.

Authors:  Clifford J Bailey
Journal:  Diabetes Care       Date:  2013-05-21       Impact factor: 19.112

10.  Hypoglycemia associated with L-asparaginase in acute lymphoblastic leukemia treatment: a case report.

Authors:  Ryuma Tanaka; Tomoo Osumi; Masashi Miharu; Tomohiro Ishii; Tomonobu Hasegawa; Takao Takahashi; Hiroyuki Shimada
Journal:  Exp Hematol Oncol       Date:  2012-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.